IGF-1 LR3Certificate of Analysis

  • Tested by Accumark Labs
  • Report 5CA9-GKY9
  • Conforms to the lab's specification
Accumark LabsCertificate of Analysis · Anaheim, CaliforniaReport 5CA9-GKY9

IGF-1 LR3

Lot AM20260925-17 · Sample received Sep 24, 2026 · Analysis completed Oct 1, 2026 · HPLC purity · Identity · Quantity (mg per vial)

Full report on Accumark Labs (opens in new tab)
IGF-1 LR3 vial
IGF-1 LR3 results reported by Accumark Labs
TestResultStatus
Purity (HPLC)
  • 99.17%
spec > 98.0%Conforms
Conforms
Identity
  • IGF-1 LR3
Conforms
Conforms
Quantity
  • 0.078 mg
Measured
Measured

Figures copied exactly from Accumark Labs's own report. Open it to check every line.

HPLC chromatogram

05101520Retention time (min)
Chromatogram as published by Accumark Labs for report 5CA9-GKY9. Purity on this certificate is the lab's figure; it excludes the unretained solvent peak near the start of the run.

HPLC testing methodology

High-Performance Liquid Chromatography (HPLC) is the standard analytical technique used to verify peptide purity. Peptide labs typically run reverse-phase HPLC with UV detection. The chromatogram displays retention time on the x-axis and UV absorbance on the y-axis. The area under each peak corresponds to compound quantity. Purity is calculated as the target peak area divided by total peak area, expressed as a percentage. A purity of 98% or above is the usual research-grade threshold.

Storage & handling

Research peptides should be stored lyophilized (freeze-dried) at -20°C or below until ready for use. Avoid repeated freeze-thaw cycles. Upon reconstitution, store at 4°C and use within 30 days. Keep away from direct light and moisture. All handling should be performed under sterile research conditions by qualified personnel following applicable laboratory safety protocols.

Intended use

IGF-1 LR3 is supplied for laboratory research purposes only. Not intended for human or veterinary use, diagnostic procedures, or clinical applications.